Travere Therapeutics
TVTX | NASDAQ
$49.70
-$0.95 (-1.88%)
At close: Nov 16, 2026, 4:00 PM ET
$49.50
-$0.20 (-0.40%)
After-hours:
Nov 16, 2026, 7:46 PM ET
Travere Therapeutics Statistics
Key statistics explainedMarket Data
$4.77B
$4.92B
1.12
1.7M
94.63M
-7.79%
N/A
NASDAQ
US89422G1076
Price Performance
0.2%
-21.8%
15.9%
30.1%
40.2%
749.6%
70.0%
0.2%
44.1%
11.4%
10.7%
Valuation
-31.86
18.08
0.28
-0.24
7.33
4.20
211.25
35.20
76.08
26.58
7.55
-32.58
-50.12
36.26
-3.1%
2.8%
1.3%
Financial Health
$131.69M
$616.16M
$471.82M
$848.23M
3.00
2.95
27.28
-6.28
4.55
0.29
-15.05
1.68
4
Margins & Profitability
94.7%
-20.5%
-15.1%
-18.7%
20.8%
9.6%
11.2%
-53.7%
Returns
-14.3%
-186.5%
-20.1%
-20.9%
-17.8%
Historical Growth (CAGR)
52.9%
24.1%
17.8%
62.3%
21.8%
0.6%
264.8%
57.8%
-5.3%
Analyst Forecasts
Buy
11
147.0%
38.2%
Feb 18, 2027
$0.44
1365.7%
$247.51M
90.8%
Fair Value Estimates
N/A
N/A
N/A
N/A
$74.00
48.9%
Cash Flow
$176.59M
$135.55M
$62.71M
$1.43
$1.87
27.1%
Income Statement
$651.04M
$616.68M
$-133.49M
$-98.07M
$-121.51M
-$1.56
$1.31M
$-244.48K
497
Add to Watchlist
Select watchlists to add or remove TVTX